Our Team

The Clear Creek Bio team has experience in all phases of drug discovery and development from the earliest stages of target validation through preclinical and clinical development, regulatory approval, and commercialization.

Vikram Sheel Kumar, MD
Co-Founder, President, and CEO

Vikram Sheel Kumar, MDCo-Founder, President, and CEO

Nadim Shohdy, PhD
Vice President, Corporate Development

Nadim Shohdy, PhDVice President, Corporate Development

John Dickson, PhD
Head of Chemistry

John Dickson, PhDHead of Chemistry

Joseph P. Vacca, PhD
Senior Advisor, Chemistry

Joseph P. Vacca, PhDSenior Advisor, Chemistry

Larry Tremaine, PhD
Senior Advisor, DMPK

Larry Tremaine, PhDSenior Advisor, DMPK

Jim Demarest, PhD
Head of Translational Science

Jim Demarest, PhDHead of Translational Science

Maryline Kienle, PhD
Manager, Project & Research Operations

Maryline Kienle, PhDManager, Project & Research Operations

Barbara Powers, MSN, PhD
Vice President, Clinical Operations

Barbara Powers, MSN, PhDVice President, Clinical Operations

David B. Sykes, MD, PhD
Co-Founder and Scientific Advisor

David B. Sykes, MD, PhDCo-Founder and Scientific Advisor

Daniel Geffken, MBA
Chief Financial Officer (Interim)

Daniel Geffken, MBAChief Financial Officer (Interim)

David P. Hesson, PhD
Development Consultant

David P. Hesson, PhDDevelopment Consultant

Andrew Levin, MD, PhD
Co-Founder

Andrew Levin, MD, PhDCo-Founder

Cindy Motaka, MPM, PMP
Chief of Staff

Cindy Motaka, MPM, PMPChief of Staff

Board Members

Burt Adelman, MD
Co-Founder and Chairman of the Board

Burt Adelman, MDCo-Founder and Chairman of the Board

Milind Deshpande, PhD

David T. Scadden, MD
Co-Founder

David T. Scadden, MDCo-Founder

Vikram Sheel Kumar, MD
Co-Founder, President, and CEO

Vikram Sheel Kumar, MDCo-Founder, President, and CEO

Scientific Advisory Board

Peter Palese, PhD

Richard Whitley, MD

585 Massachusetts Avenue
Cambridge, MA 02139
info@clearcreekbio.com